7 If felbamate is used as a concomitant AED subjects must be on felbamate for at least 2 years with a stable dose for 60 days prior to Baseline They must not have a history of white blood cell WBC count below less than or euqal to 2500/microL 2.50 1E+09/L platelets less than 100,000/microL liver function tests LFTs greater than 3 times the upper limit of normal ULN or other indication of hepatic or bone marrow dysfunction while receiving felbamate 